Denali Therapeutics Inc. Common Stock, Value, Issued
Denali Therapeutics Inc. (DNLI) had Common Stock, Value, Issued of $1.71 million as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2024-02-28
- 2023-12-31: Common Stock, Value, Issued $1.71M.
- 2023-09-30: Common Stock, Value, Issued $1.71M.
- 2023-06-30: Common Stock, Value, Issued $1.70M.
- 2023-03-31: Common Stock, Value, Issued $1.69M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2023-12-31 | $1.71M 10-K · filed 2024-02-28 |
| 2023-09-30 | $1.71M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.69M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.69M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.56M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.56M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.55M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.55M 10-K · filed 2023-02-27 |
| 2021-09-30 | $1.54M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.54M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.54M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $1.53M 10-K · filed 2022-02-28 |
| 2020-09-30 | $1.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.39M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.38M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.29M 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.29M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.28M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.28M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.27M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.27M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.26M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.25M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $1.20M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |